Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2015-10-02 Regulatory Filings
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
RayStation® will be extended to include treatment planning for the TomoTherapy® and CyberKnife® Systems
Regulatory Filings Classification · 95% confidence The document is explicitly titled "PRESS RELEASE" and announces a strategic collaboration agreement between RaySearch Laboratories AB and Accuray Incorporated regarding the integration of treatment planning support. It contains forward-looking statements and a Safe Harbor Statement referencing Form 10-K filings, which are typical characteristics of corporate news releases announcing business developments, partnerships, or product updates, rather than a formal regulatory filing like a 10-K, an Earnings Release (ER), or a specific financial report (IR, AR). Since it is a general corporate announcement about a business agreement and not a specific financial report, dividend notice, or management change, it best fits the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS). However, given the content is a strategic business announcement, and not a mandatory SEC filing disclosure (like a 10-K or 8-K summary), RNS is the most appropriate fallback, although it is essentially a press release.
2015-10-02 English
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for RaySearch Laboratories AB for the period January–June 2015. It contains comprehensive financial statements, including income statements, cash flow data, and detailed management analysis of business performance, revenue, and costs for the specified period. It is not an announcement of a report, but the report itself, containing substantive financial data. H2 2015
2015-08-28 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY 1–JUNE 30, 2015' and contains detailed financial statements, including income statements, balance sheet data, and management commentary for the half-year and second-quarter periods. It provides substantive financial analysis and performance metrics, fitting the definition of an Interim/Quarterly Report (IR). H1 2015
2015-08-28 English
RaySearch awarded treatment planning installation at premier cancer center in the US
Regulatory Filings Classification · 98% confidence The document is a press release announcing that RaySearch Laboratories has been awarded a contract to supply its RayStation treatment planning software to MD Anderson Cancer Center following an RFP process. This announcement details a significant business transaction, specifically a major sale/contract award, which relates to the company's operations and future revenue. It is not a standard regulatory filing (like 10-K, IR, or ER), nor is it a management change (MANG) or a dividend announcement (DIV). It is best classified as a general business update or announcement that doesn't fit the highly specific financial report categories. Given the options, it most closely resembles a general announcement or a regulatory filing fallback, but since it is a specific business development announcement, and there is no explicit 'Business Development' or 'Contract Award' code, I must evaluate the closest fit. It is not about financing (CAP), M&A (TAR), or insider trading (DIRS). Since it is a formal press release announcing a significant commercial event, and it doesn't fit the other specific financial/reporting codes, the most appropriate fallback is Regulatory Filings (RNS), as press releases often serve as the initial public disclosure mechanism for material, non-financial events. However, if we strictly interpret the definitions, this is a general corporate announcement. Given the available codes, RNS (Regulatory Filings/General Announcement) is the most suitable catch-all for significant, non-financial corporate news released via press release.
2015-08-27 English
Amerikanska toppkliniken väljer RayStation
Regulatory Filings Classification · 94% confidence The document is a press release dated August 27, 2015, announcing that MD Anderson Cancer Center has selected RayStation software after a Request for Proposal (RPF) process. This announcement details a significant business transaction (a major software purchase/contract) but does not fit neatly into standard SEC filings like 10-K, ER, or IR. It is an announcement regarding a business development or contract win. Given the options, this type of corporate news release, which is not a standard financial report, management change, or dividend notice, is best categorized as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if it involved significant capital structure changes, which it does not appear to. Since it is a general corporate announcement about a major customer win, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback category, as it is not explicitly covered by other codes like MANG, DIV, or TAR. The document length is short (3650 chars), but it is the primary announcement, not an announcement *of* another report.
2015-08-27 Swedish
RaySearch och Accuray ingår långsiktigt samarbetsavtal avseende onkologiinformationssystemet RayCare®
Regulatory Filings Classification · 95% confidence The document is titled "PRESSMEDDELANDE" (Press Release) and announces a long-term collaboration agreement between RaySearch and Accuray regarding the RayCare® oncology information system. It details the strategic partnership, product integration (TomoTherapy®, CyberKnife®, RayStation®), and includes standard forward-looking statements and contact information typical of a corporate announcement. This type of announcement, which is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific shareholder vote result, fits best under the general category for regulatory announcements or press releases that don't fit elsewhere. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate press release announcing a significant business development, although it is not a formal SEC filing. It is clearly not an AGM-R, 10-K, AR, ER, or CT. It is a strategic announcement, but since there is no specific code for 'Strategic Partnership Announcement', RNS serves as the best fit among the provided codes for a general, non-financial-period-specific corporate news item.
2015-07-13 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.